Phenylalanine Amide

Phenylalanine Amide

SCHEMBL3215067

NC(=O)C(N)Cc1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALPI P09923 1/20 0.61
PKM P14618 1/20 0.61
PTGS1 P23219 1/20 0.61
XIAP P98170 1/20 0.61
SLC7A5 Q01650 1/20 0.61
SLC15A1 P46059 1/20 0.53
GRB2 P62993 1/20 0.53
EPHX1 P07099 2/20 0.51
LTA4H P09960 1/20 0.50
CPA1 P15085 1/20 0.50
PTPN1 P18031 2/20 0.49
SLC1A3 P43003 2/20 0.49
SLC1A2 P43004 2/20 0.49
SLC1A1 P43005 2/20 0.49
HDAC8 Q9BY41 2/20 0.47
CES1 P23141 1/20 0.47
CYP1A2 P05177 1/20 0.46
CTSC P53634 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylalanine Amide SCHEMBL3215074 1.00 ALPI (0.61) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL18241823 0.98 ALPI (0.59) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL11349868 0.91 SLC7A5 (0.73) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL244302 0.91 SLC7A5 (0.73) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL353251 0.91 SLC7A5 (0.73) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL244303 0.91 SLC7A5 (0.73) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL23002157 0.89 SLC7A5 (0.70) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL7613303 0.89 SLC7A5 (0.70) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL353593 0.89 SLC7A5 (0.70) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Amide SCHEMBL7613300 0.89 SLC7A5 (0.70) ALPIPKMPTGS1XIAPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103826661-B Novel binding agent-drug conjugates (ADCs) and uses thereof 西雅图基因公司 2019-03-05 CN disclosed
US-20100029615-A1 BENZIMIDAZOLE DERIVATIVES PFIZER INC. 2010-02-04 US disclosed
US-5780588-A ANTICARCINOGENIC AGENT ARIZONA BOARD OF REGENTS (US) 1998-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029615-A1 BENZIMIDAZOLE DERIVATIVES ACIN1, HAT1, CCNE1 ALPI 436/4885PKM 1417/4885PTGS1 4396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.